Skip to main content
SpringerLink
Log in

Omeprazole

Gastrin and gastric endocrine cell data from clinical studies

  • Review Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Gastric enterochromaffin-like cell carcinoids have been detected in rats exposed lifelong to omeprazole. By inhibiting acid secretion, omeprazole causes hypergastrinemia which, with prolonged exposure, exerts a trophic effect on enterochromaffin-like cells with eventual enterochromaffin-like cell carcinoid formation in some animals. This mechanism seems to explain the appearance of enterochromaffin-like cell carcinoids in human hypergastrinemic states, whether associated with hyperchlorhydria, eg, Zollinger-Ellison syndrome, or with hypochlorhydria, eg, pernicious anemia (nonantral atrophic gastritis). Omeprazole produces modest serum gastrin elevations in humans when monitored over a 24-hr period. Gastrin levels are markedly lower and less sustained than in the above hypergastrinemic states. Extensive gastric biopsy data from patients enrolled in long-term studies indicate that omeprazole administration is not associated with clinically significant changes in the human oxyntic endocrine cell population. Man and rat differ markedly both in their gastrin response to a given level of acid inhibition and in their response to the trophic influence of gastrin on enterochromaffin-like cells. The rat model is a false indicator of risk in man.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Havu N: Enterochromaffin-like cell carcinoids of gastric mucosa in rats after life-long inhibition of gastric secretion. Digestion 35(suppl 1):42–55, 1986

    Google Scholar 

  2. Ekman L, Hansson E, Havu N, Carlsson E, Lundberg G: Toxicological studies on omeprazole. Scand J Gastroenterol 20(suppl 108):53–69, 1985

    Google Scholar 

  3. Larsson H, Hakanson R, Mattsson H, Ryberg B, Sundler F, Carlsson E: Omeprazole: Its influence on gastric acid secretion, gastrin, and ECL cells. Toxicol Pathol 16:267–272, 1988

    Google Scholar 

  4. Ryberg B, Mattsson H, Sundler F, Hakanson R, Carlsson E: Effect of inhibition of gastric acid secretion in rats on plasma gastrin levels and density of enterochromaffin-like cells in the oxyntic mucosa.In Proceedings from 6th International Symposium on Gastrointestinal Hormones. J Krailer, GS Marks, (eds). Vancouver, Canada National Research Council of Canada, 1986, pp 34–35

    Google Scholar 

  5. Larsson H, Carlsson E, Mattsson H, Lundell L, Sundler F, Sundell G, Wallmark B, Watanabe T, Hakanson R: Plasma gastrin and gastric enterochromaffin-like cell activation and proliferation, Gastroenterology 90:391–399, 1986

    Google Scholar 

  6. Ryberg B, Mattsson H, Carlsson E: Effects of omeprazole and ranitidine on gastric acid secretion, blood gastrin levels and [3H]-thymidine incorporation in the oxyntic mucosa from dogs and rats. Digestion 39:91–99, 1988

    Google Scholar 

  7. Mattsson H, Ryberg B, Hakanson R, Lundell L Sundler F: Correlation between plasma gastrin and gastric mucosal ECL-cell density in rats after acid inhibition, partial fundectomy and gastrin-17 infusion. Monte-Carlo, Monaco, The International Symposium on Omeprazole, Nov 11–12, 1988, p 40

  8. Mattsson H, Havu N, Carlsson K, Brautigam J, Lundell L, Carlsson E: Partial fundectomy results in hypergastrinemia and the development of gastric ECL-cell carcinoids in the rat. Gastroenterology 96:A330, 1989

    Google Scholar 

  9. Penston J, Wormsley KG: Achlorhydra. Hypergastrinaemia: Carcinoids—a flawed hypothesis? Gut 28:488–505, 1987

    Google Scholar 

  10. Havu H, Mattson H, Ekman L, Carlsson E: ECL-cell carcinoids in the rat gastric mucosa following long-term administration of ranitidine. Digestion 45:189–195, 1990

    Google Scholar 

  11. Allen JM, Adrian TE, Webster J, Howe A, Bloom SR: Effect of single dose of omeprazole on the gastrointestinal peptide response to food. Hepatogastroenterology 31:44–46, 1984

    Google Scholar 

  12. Festen HP, Tuynman HA, Defize J, Pals G, Frants RR, Straub JP, Meuwissen SG: Effect of single and repeated doses of omeprazole on gastric acid and pepsin secretion and fasting serum gastrin and serum pepsinogen I levels. Dig Dis Sci 31:561–566, 1986

    Google Scholar 

  13. Festen HP, Thijs JC, Lamers CB, Jansen JM, Pals G, Frants RR, Defize J, Meuwissen SG: Effect of oral omeprazole on serum gastrin and serum pepsinogen I levels. Gastroenterology 87:1030–1034, 1984

    Google Scholar 

  14. Karvonen AL, Keyrilainen O, Uusitalo A, Salaspuro M, Tarpila S, Andren K, Helander HF: Effects of omeprazole in duodenal ulcer patients. Scand J Gastroenterol 21:449–454, 1986

    Google Scholar 

  15. Koop H, Schwarting H, Knorr-Marin A, Wilhardt C, Moser T, Arnold R: Influence of chronic omeprazole treatment on gastric endocrine function. Klin Wochenschr 65:169–173, 1987

    Google Scholar 

  16. Naesdal J, Bankel M, Bodemar G, Gotthard, R, Lundquist G, Walan A: The effect of 20 mg omeprazole daily on serum gastrin, 24-h intragastric acidity, and bile acid concentrations in duodenal ulcer patients. Scand J Gastroenterol 22:5–12, 1987

    Google Scholar 

  17. Sharma B, Axelson M, Pounder RP, Lundborg P, Ohman M, Santana A, Talbot M, Cederberg C: Acid secretory capacity and plasma gastrin concentration after administration of omeprazole to normal subjects. Aliment Pharmacol Ther 1:67–76, 1987

    Google Scholar 

  18. Brunner G, Creutzfeldt W, Harke U, Lamberts R: Therapy with omeprazole in patients with peptic ulcerations resistant to extended high-dose ranitidine treatment. Digestion 39:80–90, 1988

    Google Scholar 

  19. Crobach LF, Jansen JB, Lamers CB: Effect of intermittent weekend therapy with omeprazole on basal and bombesin and pentagastrin-stimulated gastric acid and serum gastrin. Scand J Gastroenterol 23:407–412, 1988

    Google Scholar 

  20. Hemery P, Galmiche JP, Roze C, Isal JP, Bruley des Varannes S, Lavignolle A, Le Bodic L: Low dose omeprazole effects on gastric acid secretion in normal man. Gastroenterol Clin Biol 11:148–153, 1987

    Google Scholar 

  21. Van Deventer GM, Cagliola A, Whipple J, Humphries T: Duodenal ulcer healing with omeprazole: A multicenter double-blind ranitidine controlled study. Gastroenterology 94:A476, 1988

    Google Scholar 

  22. Lanzon-Miller S, Pounder RE, Hamilton MR, Ball S, Chronos NAF, Olausson FRM, Cederberg C: Twenty-four-hour intragastric acidity and plasma gastrin concentration before and during treatment with either ranitidine or omeprazole. Aliment Pharmacol Ther 1:239–252, 1987

    Google Scholar 

  23. Karnes WE, Berlin RG, Maxwell V, Sytnik B, Root JK, Walsh JH: Prolonged inhibition of acid secretion causes hypergastrinemia without altering pH inhibition of gastrin release in humans. Aliment Pharmacol Therap 4:443–456, 1990

    Google Scholar 

  24. Lind T, Cederberg C, Olausson M, Olbe L: 24-Hour intragastric acidity and plasma gastrin after omeprazole treatment or proximal gastric vagotomy in duodenal ulcer patients. Gastroenterology 94:A265, 1988

    Google Scholar 

  25. Simonsson M, Eriksson S, Hakanson R, Lind T, Lonroth H, Lundell L, O'Connor DT, Sundler F: Endocrine cells in the human oxyntic mucosa: a histochemical study. Scand J Gastroenterol 23:1089–1099, 1988

    Google Scholar 

  26. Hakanson R, Ekelund M, Sundler F: Activation and proliferation of gastric endocrine cells.In Evolution and Tumor Pathology of the Neuroendocrine System. S Falkmer, R Hakanson, F. Sundler (eds). Amsterdam. Elsevier Science Publishers, 1984, pp 371–398

    Google Scholar 

  27. Hakanson R, Owman C, Sporrong B, Sundler F: Electron microscopic identification of the histamine-storing argyrophil (enterochromaffin-like) cells in the rat stomach. Z Zellforsch Mikrosk Anat 122:460–466, 1971

    Google Scholar 

  28. Noll WW, Levine RJ: Histidine decarboxylase in gastric tissues of primates. Biochem Pharmacol 19:1043–1053, 1970

    Google Scholar 

  29. Roberts LJ, Bloomgarden ZT, Marney SR Jr, Rabin D, Oates JA: Histamine release from a gastric carcinoid: provocation by pentagastrin and inhibition by somatostatin. Gastroenterology 84:272–275, 1983

    Google Scholar 

  30. Solcia E, Capella C, Vassalo G, Buffa R: Endocrine cells of the gastric mucosa.In international Review of Cytology. GH Borune JF Danielli, KW Jeon (eds). New York, Academic Press, 1975, pp 223–286

    Google Scholar 

  31. Grimelius L: A silver nitrate stain for α2 cells in human pancreatic islets. Acta Soc Med Upsala 73:243–270, 1968

    Google Scholar 

  32. Sevier AC, Munger BL: A silver method for paraffin sections of neural tissue. J Neuropathol Exp Neurol 24:130–135, 1965

    Google Scholar 

  33. Helander HF, Keyrilainen O, Uusitalo A, Karvonen AL: Stereological data on endocrine cells of the gastric corpus in patients treated with omeprazole. Gut 26:A557, 1985

    Google Scholar 

  34. Helander HF: Oxyntic mucosa histology in omeprazole-treated patients suffering from duodenal ulcer or Zollinger-Ellison syndrome. Digestion 35(suppl 1):123–129, 1986

    Google Scholar 

  35. Helander HF, Leth R, Olbe L: Stereological investigations on human gastric mucosa: I. Normal oxyntic mucosa. Anat Rec 216:373–380, 1986

    Google Scholar 

  36. Sundler F: Fasting gastrin levels and histology of gastric biopsies from peptic ulcer patients before and after treatment with omeprazole or H2-receptor antagonists. Haessle Report 222-0096, 1986

  37. Dayal Y, Berlin R, Collen M, Bhatnagar R: Does prolonged omeprazole administration affect enterochromaffin-like cell populations in hypersecretors? Gastroenterology 96:A113, 1989

    Google Scholar 

  38. Bardram L, Thomsen P, Stadil F: Gastric endocrine cells in omeprazole-treated and untreated patients with Zollinger-Ellison syndrome. Digestion 35(suppl 1):116–122, 1986

    Google Scholar 

  39. Larsson H, Helander H, Hakanson R, Mattsson H, Ryberg B, Sundler F: Omeprazole: Its influence on gastric acid secretion, gastrin and ECL cells. Toxicol Pharmacol 15:363–364, 1987

    Google Scholar 

  40. Lloyd-Davies KA, Rutgersson K, Solvell L: Omeprazole in the treatment of Zollinger-Ellison syndrome: A 4-yr international study. Aliment Pharmacol Ther 2:13–32, 1988

    Google Scholar 

  41. Maton PN, Lack E, McArthur KE, Collen MJ, Frucht H, Miller LS, Saeed ZA, Stark HA, Gardner JD, Jensen RT: Effects of long term omeprazole on gastric acid secretion and mucosal histology in patients with Zollinger-Ellison syndrome. Gastroenterology 94:A288, 1988

    Google Scholar 

  42. Helander HF: Morphometric investigations of endocrine cells in the oxyntic mucosa of Zollinger-Ellison patients. Haessle Report 222-0097, 1986

  43. Helander HF: Morphometric investigations of endocrine cells in the oxyntic mucosa of Zollinger-Ellison patients. Haessle Report 222-0097, 1988, Addendum

  44. Cadiot G, Lehy T, Mignon M, Ruszniewski PH, Elouaer-Blanc L, Bonfils S, Lewin M: Comparative behavior of gastric endocrine cells and serum gastrin levels in Zollinger-Ellison patients during long-term treatment with omeprazole or H2-receptor antagonists. Gastroenterology 94:A56, 1988

    Google Scholar 

  45. Lehy T, Mignon M, Cadiot G, Elouaer-Blanc L, Ruszniewski PH, Lewin MJM, Bonfils S: Gastric endocrine cell behavior in Zollinger-Ellison patients upon long-term potent antisecretory treatment. Gastroenterology 96:1029–1040, 1989

    Google Scholar 

  46. Lamberts R, Creutzfeldt W, Stockmann F, Jacubaschke U, Maas S, Brunner G: Long-term omeprazole treatment in man: Effects on gastric endocrine cell populations. Digestion 39:126–135, 1988

    Google Scholar 

  47. Solcia E, Rindi G, Havu N, Elm G: Qualitative studies of gastric endocrine cells in patients treated long-term with omeprazole. Scand J Gastroenterol 24 (suppl 166)129–137, 1989

    Google Scholar 

  48. Solcia E, Bordi C, Creutzfeldt W, Dayal Y, Dayan AD, Falkmer S, Grimelius L, Havu N: Histopathological classification of nonantral gastric endrocrine growths in man. Digestion 41:185–200, 1988

    Google Scholar 

  49. Carlsson E, Larsson H, Mattsson H, Ryberg B, Sundell G: Pharmacology and toxicology of omeprazole—with special reference to the effects on the gastric mucosa. Scand J Gastroenterol 21(suppl 118):31–38, 1986

    Google Scholar 

  50. Hakanson R, Larsson LI, Liedberg G, Sundler F: the histamine-storing enterochromaffin-like cells of the rat stomach.In Chromaffin, Enterochromaffin and Related Cells. RE Coupland, T Fujita (eds). Amsterdam, Elsevier, 1976, pp 243–263

    Google Scholar 

  51. Stachura J, Tarnawski A, Hollander D, Ulrich TR, Gergely H: Aging-associated hyperplasia of enterochromaffin-like cells in the gastric mucosa of rats. A potential factor predisposing to carcinoids? Gastroenterology 92:1651, 1987

    Google Scholar 

  52. Majka JA, Scher S: Spontaneous gastric carcinoid tumor in an aged Sprague-Dawley rat. Vet Pathol 26:88–90, 1989

    Google Scholar 

  53. MacDonald RA: A study of 356 carcinoids of the gastrointestinal tract. Am J Med 21:867–878, 1956

    Google Scholar 

  54. Goodwin JD: Carcinoid tumors. An analysis of 2,837 cases. Cancer 36:560–569, 1975

    Google Scholar 

  55. Harvey RF, Bradshaw MJ, Davidson CM, Wilkinson SP, Davies PS: Multifocal gastric carcinoid tumors, achlorhydria and hypergastrinemia. Lancet 1:951–953, 1985

    Google Scholar 

  56. Carney JA, Go VLW, Fairbanks VF, Moore SB, Alport EC, Nora FE: The syndrome of gastric argyrophic carcinoid tumors and non-atrial gastric atrophy. Ann Intern Med 99:761–766, 1983

    Google Scholar 

  57. Hodges JR, Isaacson P, Wright R: Diffuse enterochromaffin-like (ECL) hyperplasia and multiple carcinoids: A complication of pernicious anemia. Gut 22:237–241, 1981

    Google Scholar 

  58. Wilander E: Achylia and the development of gastric carcinoids. Virchows Arch (Pathol Anat) 394:151–160, 1984

    Google Scholar 

  59. Wilander E, El-Salhym M, Pitkanen P: Histopathology of gastric carcinoids: A survey of 42 cases. Histopathology 8:183–193, 1984

    Google Scholar 

  60. Borch K, Renvall H, Liedberg G: Gastric endocrine cell hyperplasia and carcinoid tumors in pernicious anemia. Gastroenterology 88:638–648, 1985

    Google Scholar 

  61. Borch K, Renvall H, Liedberg G, Anderson BN: Relations between circulating gastrin and endocrine cell proliferation in the atrophic gastric fundic mucosa. Scand J Gastroenterol 21:357–363, 1986

    Google Scholar 

  62. Solcia E, Capella C, Vasallo F, Buffa R: Endocrine cells of the gastric mucosa. Int Rev Cytol 42:223–286, 1975

    Google Scholar 

  63. Bordi C, D'Adda T, Pilato FP, Ferrari C: Carcinoid (ECL cell) tumor of the oxyntic mucosa of the stomach: a hormone dependent neoplasm?In Progress in Surgical Pathology, Vol III. CM Fenoglio-Preiser, M Wolff, F Filice (eds). New York, Macmillan, 1988, pp 177–195

    Google Scholar 

  64. Hakanson R, Eklund M, Sundler F: Activation and proliferation of gastric endocrine cells.In Evolution and Tumor Pathology of the Neuroendocrine System. S Falkmer, R Hakanson, F Sundler (eds). New York, Elsevier, 1984, pp 371–398

    Google Scholar 

  65. Solcia E, Capella C, Vassallo G: Endocrine cells of the stomach and pancreas in states of gastric hypersecretion. Rend. R Gastroenterol 2:147–158, 1970

    Google Scholar 

  66. Bordi C, Senatore S, Missale G: Gastric carcinoid following gastrojejunostomy. Am J Dig Dis 21:667–671, 1976

    Google Scholar 

  67. Solcia E, Capella C, Sessa F, Rindi G, Cornaggia M: Gastric carcinoids and related endocrine growth. Digestion 35(suppl. 1): 3–22, 1986

    Google Scholar 

  68. Bordi C, Ravazzola M, De Vita O: Pathology of endocrine cells in gastric mucosa. Ann Pathol 3:19–28, 1983

    Google Scholar 

  69. Rosai J: Stomach multiple carcinoid tumors. 7th Congress of the European Society of Pathology (Case 9.5). Valencia, Spain. September 1979

  70. Duggan M, Anderson C: Mixed type Zollinger-Ellison syndrome in a florid case of multiple endocrine neoplasia type 1. Am J Clin Pathol 82:481–486, 1984

    Google Scholar 

  71. Lattes R, Grossi C: Carcinoid tumors of the stomach. Cancer 9:698–711, 1956

    Google Scholar 

  72. Mignon M, Lehy T, Bonneford A, Ruszniewski P, Labeille D, Bonfils S: Development of gastric argyophil carcinoid tumors in a case of Zollinger-Ellison syndrome with primary hyperparathyroidism during long term antisecretory therapy. Cancer 59:159–162, 1986

    Google Scholar 

  73. Magellanes F, Quigley TM, Eisenberg MH, Bousack M, Delaney JP: The relationship of lumenal pH and distension to antral G cell numbers. J Surg Res 30:349–353, 1981

    Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Merck Sharp & Dohme Research Laboratories, 19486, West Point, Pennsylvania

    R. G. Berlin

Authors
  1. R. G. Berlin
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Berlin, R.G. Omeprazole. Digest Dis Sci 36, 129–136 (1991). https://doi.org/10.1007/BF01300745

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF01300745

Key Words

Search

Navigation